VIRGINIA RETIREMENT SYSTEMS ET AL - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 175 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
VIRGINIA RETIREMENT SYSTEMS ET AL ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$772,000
+11.7%
6,900
-27.4%
0.01%
-10.0%
Q1 2020$691,000
-47.8%
9,500
-25.2%
0.01%
-28.6%
Q4 2019$1,324,000
+26.7%
12,700
+21.0%
0.01%
+16.7%
Q3 2019$1,045,000
-2.6%
10,500
+11.7%
0.01%0.0%
Q2 2019$1,073,000
-6.2%
9,400
+3.3%
0.01%
-14.3%
Q1 2019$1,144,000
+6.7%
9,100
+15.2%
0.01%0.0%
Q4 2018$1,072,000
-48.6%
7,900
+3.9%
0.01%
-41.7%
Q3 2018$2,086,000
+17.1%
7,600
-11.6%
0.02%
+9.1%
Q2 2018$1,782,000
+6.8%
8,600
-14.9%
0.02%
+10.0%
Q1 2018$1,668,000
+238.3%
10,100
+180.6%
0.02%
+233.3%
Q4 2017$493,000
-3.3%
3,600
-14.3%
0.01%0.0%
Q2 2017$510,000
-67.9%
4,200
-72.0%
0.01%
-70.0%
Q1 2017$1,588,000
+10.0%
15,000
+5.6%
0.02%0.0%
Q4 2016$1,443,000
+9.6%
14,200
+10.1%
0.02%
+5.3%
Q3 2016$1,317,000
-12.4%
12,900
+2.4%
0.02%
-13.6%
Q2 2016$1,503,000
-1.0%
12,600
-10.0%
0.02%
-4.3%
Q4 2015$1,518,000
+22.2%
14,000
-3.4%
0.02%
+21.1%
Q3 2015$1,242,000
-26.7%
14,500
-13.7%
0.02%
-26.9%
Q2 2015$1,695,000
+11.0%
16,800
-15.2%
0.03%
+13.0%
Q1 2015$1,527,000
+28.6%
19,800
-11.2%
0.02%
+21.1%
Q4 2014$1,187,000
+42.0%
22,300
+25.3%
0.02%
+35.7%
Q3 2014$836,000
+134.2%
17,800
+235.8%
0.01%
+100.0%
Q1 2014$357,000
+58.0%
5,300
+23.3%
0.01%
+40.0%
Q4 2013$226,000
-75.2%
4,300
-79.6%
0.01%
-75.0%
Q3 2013$913,000
+9.5%
21,100
-5.4%
0.02%
+25.0%
Q2 2013$834,00022,3000.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders